WHO ICTRP trial
Berberine Chloride Stabilizes Coronary Atherosclerotic Plaques in Clinical…
ChiCTR-TRC-13003691 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-13003691 |
|---|---|
| Public title | Berberine Chloride Stabilizes Coronary Atherosclerotic Plaques in Clinical Research |
| Scientific title | Berberine Chloride Stabilizes Coronary Atherosclerotic Plaques in Clinical Research |
| Primary sponsor | Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | coronary heart disease |
| Interventions | Treatment group:Rosuvastatin+Berberine;Control group:Rosuvastatin |
| Registration date | Jul 22, 2013 |
| Target size | Treatment group:80;Control group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: